Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Robertson, L. P.
Right arrow Articles by Hickling, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, L. P.
Right arrow Articles by Hickling, P.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 473-474
© 2001 British Society for Rheumatology

Letters to the Editor

Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab

L. P. Robertson and P. Hickling

Department of Rheumatology, Derriford Hospital, Derriford Road, Plymouth PL6 8DH, UK

The first 10% of the full text of this article appears below.

SIR, The recurrent oral and genital ulceration of Behçet's syndrome (BS) can be very distressing and is associated with considerable physical and psychological morbidity. We describe a case of Behçet's syndrome in a 65-yr-old woman whose orogenital ulceration was unresponsive to a wide range of topical and systemic treatments. Treatment with infliximab, a chimeric anti-tumour necrosis factor {alpha} . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. Iwata, K. Saito, K. Yamaoka, S. Tsujimura, M. Nawata, K. Suzuki, and Y. Tanaka
Effects of anti-TNF-{alpha} antibody infliximab in refractory entero-Behcet's disease
Rheumatology, August 1, 2009; 48(8): 1012 - 1013.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. P. Sfikakis, N. Markomichelakis, E. Alpsoy, S. Assaad-Khalil, B. Bodaghi, A. Gul, S. Ohno, N. Pipitone, M. Schirmer, M. Stanford, et al.
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Rheumatology, May 1, 2007; 46(5): 736 - 741.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. G. Barnes
Treatment of Behcet's syndrome
Rheumatology, March 1, 2006; 45(3): 245 - 247.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
E. B. Suhler, J. R. Smith, M. S. Wertheim, A. K. Lauer, D. E. Kurz, T. D. Pickard, and J. T. Rosenbaum
A Prospective Trial of Infliximab Therapy for Refractory Uveitis: Preliminary Safety and Efficacy Outcomes
Arch Ophthalmol, July 1, 2005; 123(7): 903 - 912.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
L.M. Al-Otaibi, S.R. Porter, and T.W.J. Poate
Behcet's Disease: A Review
Journal of Dental Research, March 1, 2005; 84(3): 209 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. Sakellariou, C. Berberidis, and P. Vounotrypidis
A case of Behcet's disease with scleromalacia perforans
Rheumatology, February 1, 2005; 44(2): 258 - 260.
[Full Text] [PDF]

Home page
 Br J OphthalmolHome page
M R Stanford
Behcet's syndrome
Br J Ophthalmol, April 1, 2003; 87(4): 381 - 382.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
P P Sfikakis
Behcet's disease: a new target for anti-tumour necrosis factor treatment
Ann Rheum Dis, November 1, 2002; 61(90002): ii51 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Estrach, S. Mpofu, and R. J. Moots
Behcet's syndrome: response to infliximab after failure of etanercept
Rheumatology, October 1, 2002; 41(10): 1213 - 1214.
[Full Text] [PDF]